Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMaven Income 1 Regulatory News (MIG1)

Share Price Information for Maven Income 1 (MIG1)

Share Price is delayed by 15 minutes
Get Live Data
33.80    0.00 (0.00%)
Bid:
32.80
Ask:
34.80
Spread: 2.00 (6.098%)
Market Cap: £70.05m
MIG1 Live PriceLast checked at - London Stock Exchange

Intraday Maven Income 1 Share Chart

Result of AGM

6 Jul 2017 14:08

RNS Number : 3534K
Maven Income & Growth VCT PLC
06 July 2017
 

Maven Income and Growth VCT PLC

 

Result of Annual General Meeting

 

At the Annual General Meeting of the Company held in 5th Floor, 1-2 Royal Exchange Buildings, London EC3V 3LF on Thursday 6 July 2017 at 12.00 noon, all of the Resolutions put to the Meeting were passed.

 

At the record date for the Annual General Meeting, being 4 July 2017, the total number of voting rights in the Company stood at 54,052,884 and the total shares in issue were 54,052,884. In accordance with the provisions of E.2.2 of the UK Corporate Governance Code, the Company advises that for the Annual General Meeting, valid proxy appointments were made in respect of 4,089,566 shares and that the number of proxy votes lodged for each Resolution were as follows:

 

Resolutions

For

Discretion

Against

Withheld

Total

1

To receive the Directors' Report and Financial Statements

4,032,726

53,840

0

3,000

4,089,566

2

To approve the Directors' Remuneration Report

3,488,515

60,840

513,859

26,352

4,089,566

3

To approve the Directors' Remuneration Policy

3,473,145

65,840

517,844

32,737

4,089,566

4

To re-elect Mr John Pocock as a Director

 

3,980,895

59,023

38,166

11,482

4,089,566

5

To re-elect Mr Arthur MacMillan as a Director

 

3,965,376

59,023

49,700

15,467

4,089,566

6

To re-elect Mrs Fiona Wollocombe as a Director

3,949,100

59,023

64,312

17,131

4,089,566

7

To re-appoint Deloitte LLP as Auditor

 

3,636,583

52,023

394,479

6,481

4,089,566

8

To authorise the Directors to fix the remuneration of the Auditor

4,016,288

52,023

4,666

16,589

4,089,566

9

To renew the Company's authority to allot shares

3,980,954

52,023

33,536

23,053

4,089,566

10

To authorise the Directors to disapply pre-emption rights

3,219,484

59,023

679,634

131,425

4,089,566

11

To renew the Company's authority to purchase its own shares

3,607,604

59,023

416,749

6,190

4,089,566

12

To amend the notice period for a General Meeting.

3,680,857

67,403

336,792

4,514

4,089,566

A vote withheld is not a vote in law and any such votes have not been included in the votes for or against the respective Resolutions. The voting figures will be available to view at: www.mavencp.com/migvct. 

 

A copy of the Resolutions which require to be filed at Companies House have also been submitted to the National Storage Mechanism and will shortly be available for inspection at: www.morningstar.co.uk/uk/NSM.

 

Issued on behalf of the Board

 

Maven Capital Partners UK LLP

Secretary

 

6 July 2017

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RAGSSWFDMFWSESW
Date   Source Headline
2nd Jun 20264:19 pmRNSAnnual Financial Report
1st May 20263:20 pmRNSTransaction in Own Shares
30th Apr 20265:09 pmRNSTransaction in Own Shares
30th Apr 202610:51 amRNSAdmission of Further Securities to Trading
29th Apr 202612:23 pmRNSIssue of Equity
27th Apr 20263:29 pmRNSUnaudited Net Asset Value and Dividend Declaration
20th Apr 202612:23 pmRNSPublication of a Supplementary Prospectus
15th Apr 202611:17 amRNSAdmission of Further Securities to Trading
14th Apr 202611:06 amRNSIssue of Equity
8th Apr 20269:27 amRNSAdmission of Further Securities to Trading
25th Mar 202610:49 amRNSAdmission of Further Securities to Trading
24th Mar 202612:08 pmRNSIssue of Equity
4th Feb 20267:00 amRNSStatement re Offer for Subscription
29th Jan 20264:54 pmRNSTransaction in Own Shares
21st Jan 202611:01 amRNSAdmission of Further Securities to Trading
20th Jan 20262:05 pmRNSAdmission of Further Securities to Trading
16th Jan 20269:39 amRNSIssue of Equity
15th Jan 202610:27 amRNSDirector/PDMR Shareholding
15th Jan 202610:26 amRNSDirector/PDMR Shareholding
15th Jan 202610:26 amRNSDirector/PDMR Shareholding
15th Jan 20269:50 amRNSIssue of Equity
14th Jan 20262:33 pmRNSUnaudited NAV - Dividend Investment Scheme
4th Dec 202510:35 amRNSUnaudited NAV and Second Interim Dividend
13th Nov 20253:39 pmRNSResult of General Meeting
29th Oct 20257:00 amRNSHalf-year Report
16th Oct 20254:43 pmRNSTransaction in Own Shares
2nd Oct 20254:42 pmRNSPublication of a Prospectus
15th Sep 20251:06 pmRNSNet Asset Value(s)
29th Aug 20257:00 amRNSIssue of Equity
20th Aug 20252:12 pmRNSStatement re Dividend Investment Scheme
23rd Jul 20254:33 pmRNSTransaction in Own Shares
18th Jul 202510:08 amRNSIssue of Equity - Dividend Investment Scheme
16th Jul 20257:08 amRNSStatement re Offer for Subscription
11th Jul 20253:56 pmRNSStatement re Dividend Investment Scheme
11th Jul 20252:58 pmRNSStatement re Unaudited NAV and Interim Dividend
10th Jul 20252:32 pmRNSResult of AGM
28th May 20254:18 pmRNSAnnual Financial Report
7th May 20254:35 pmRNSTransaction in Own Shares
6th May 202511:51 amRNSIssue of Equity
25th Apr 20254:19 pmRNSUnaudited NAV and Proposed Final Dividend
17th Apr 202512:56 pmRNSPublication of Suppl.Prospcts
7th Apr 20257:00 amRNSIssue of Equity - Replacement
4th Apr 20256:15 pmRNSIssue of Equity
1st Apr 202512:59 pmRNSStatement re Offers for Subscription - Closed
27th Mar 20251:02 pmRNSIssue of Equity
27th Mar 202510:25 amRNSUpdate re: Offers for Subscription
24th Mar 20253:23 pmRNSUnaudited Net Asset Value
29th Jan 20254:35 pmRNSTransaction in Own Shares
28th Jan 202512:15 pmRNSStatement re Offer for Subscription
28th Jan 202511:27 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.